Company Filing History:
Years Active: 2023
Title: Naoko Wada: Innovator in Genetic Modification
Introduction
Naoko Wada is a prominent inventor based in Shizuoka, Japan. She has made significant contributions to the field of genetic engineering, particularly in the development of genetically modified non-human animals. Her work has implications for therapeutic agent development and targeted drug therapies.
Latest Patents
Naoko Wada holds a patent for a groundbreaking invention titled "Non-human animal having human CD3 gene substituted for endogenous CD3 gene." This patent describes genetically modified non-human animals that are deficient in specific CD3 genes and functionally express human CD3 genes. The invention allows for mature T cell differentiation and the production of immunocompetent cells, which can enhance the evaluation and screening processes in therapeutic development.
Career Highlights
Wada is associated with Chugai Seiyaku Kabushiki Kaisha, a leading pharmaceutical company in Japan. Her innovative work in genetic modification has positioned her as a key figure in the field, contributing to advancements in medical research and therapeutic applications.
Collaborations
Naoko Wada has collaborated with notable colleagues, including Koichi Jishage and Otoya Ueda. These partnerships have fostered a collaborative environment that enhances research and development efforts in genetic engineering.
Conclusion
Naoko Wada's contributions to genetic modification and her innovative patent highlight her role as a leading inventor in the field. Her work continues to pave the way for advancements in therapeutic methods and drug development.